These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 19201877)

  • 1. Absence of mucosal immunity in the human upper respiratory tract to the commensal bacteria Neisseria lactamica but not pathogenic Neisseria meningitidis during the peak age of nasopharyngeal carriage.
    Vaughan AT; Gorringe A; Davenport V; Williams NA; Heyderman RS
    J Immunol; 2009 Feb; 182(4):2231-40. PubMed ID: 19201877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neisseria lactamica selectively induces mitogenic proliferation of the naive B cell pool via cell surface Ig.
    Vaughan AT; Brackenbury LS; Massari P; Davenport V; Gorringe A; Heyderman RS; Williams NA
    J Immunol; 2010 Sep; 185(6):3652-60. PubMed ID: 20709949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis.
    Evans CM; Pratt CB; Matheson M; Vaughan TE; Findlow J; Borrow R; Gorringe AR; Read RC
    Clin Infect Dis; 2011 Jan; 52(1):70-7. PubMed ID: 21148522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa.
    Davenport V; Groves E; Hobbs CG; Williams NA; Heyderman RS
    Cell Microbiol; 2007 Apr; 9(4):1050-61. PubMed ID: 17166235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?
    Gorringe AR
    Expert Rev Vaccines; 2005 Jun; 4(3):373-9. PubMed ID: 16026250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of monoclonal antibodies to Neisseria lactamica in an antigen selection to Neisseria meningitides B vaccine.
    De Gaspari EN
    Hybridoma (Larchmt); 2008 Oct; 27(5):387-93. PubMed ID: 18803504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.
    Braun JM; Beuth J; Blackwell CC; Giersen S; Higgins PG; Tzanakaki G; Unverhau H; Weir DM
    Vaccine; 2004 Feb; 22(7):898-908. PubMed ID: 15040943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the inflammatory responses of human meningeal cells following challenge with Neisseria lactamica and with Neisseria meningitidis.
    Fowler MI; Yin KY; Humphries HE; Heckels JE; Christodoulides M
    Infect Immun; 2006 Nov; 74(11):6467-78. PubMed ID: 16954390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant.
    Sardiñas G; Reddin K; Pajon R; Gorringe A
    Vaccine; 2006 Jan; 24(2):206-14. PubMed ID: 16115701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies.
    Li Y; Zhang Q; Winterbotham M; Mowe E; Gorringe A; Tang CM
    Infect Immun; 2006 Nov; 74(11):6348-55. PubMed ID: 16966413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human airway epithelial cell responses to Neisseria lactamica and purified porin via Toll-like receptor 2-dependent signaling.
    Liu X; Wetzler LM; Nascimento LO; Massari P
    Infect Immun; 2010 Dec; 78(12):5314-23. PubMed ID: 20937766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neisseria lactamica Controlled Human Infection Model.
    Dale AP; Gbesemete DF; Read RC; Laver JR
    Methods Mol Biol; 2022; 2414():387-404. PubMed ID: 34784048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
    Gorringe A; Halliwell D; Matheson M; Reddin K; Finney M; Hudson M
    Vaccine; 2005 Mar; 23(17-18):2210-3. PubMed ID: 15755597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens.
    Vaughan TE; Skipp PJ; O'Connor CD; Hudson MJ; Vipond R; Elmore MJ; Gorringe AR
    Vaccine; 2006 Jun; 24(25):5277-93. PubMed ID: 16682101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal Inoculation of the Commensal Neisseria lactamica Inhibits Carriage of Neisseria meningitidis by Young Adults: A Controlled Human Infection Study.
    Deasy AM; Guccione E; Dale AP; Andrews N; Evans CM; Bennett JS; Bratcher HB; Maiden MC; Gorringe AR; Read RC
    Clin Infect Dis; 2015 May; 60(10):1512-20. PubMed ID: 25814628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors affecting Neisseria meningitidis and Neisseria lactamica carrier state].
    Krízová P; Vlcková J
    Epidemiol Mikrobiol Imunol; 1998 Dec; 47(4):131-6. PubMed ID: 9919812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children.
    Gold R; Goldschneider I; Lepow ML; Draper TF; Randolph M
    J Infect Dis; 1978 Feb; 137(2):112-21. PubMed ID: 415097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial.
    Dale AP; Theodosiou AA; Gbesemete DF; Guy JM; Jones EF; Hill AR; Ibrahim MM; de Graaf H; Ahmed M; Faust SN; Gorringe AR; Polak ME; Laver JR; Read RC
    Lancet Microbe; 2022 Dec; 3(12):e931-e943. PubMed ID: 36462524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diversity and carriage dynamics of Neisseria lactamica in infants.
    Bennett JS; Griffiths DT; McCarthy ND; Sleeman KL; Jolley KA; Crook DW; Maiden MC
    Infect Immun; 2005 Apr; 73(4):2424-32. PubMed ID: 15784588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid characterization of outer-membrane proteins in Neisseria lactamica by SELDI-TOF-MS (surface-enhanced laser desorption ionization-time-of-flight MS) for use in a meningococcal vaccine.
    Mukhopadhyay TK; Halliwell D; O'Dwyer C; Shamlou PA; Levy MS; Allison N; Gorringe A; Reddin KM
    Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):175-82. PubMed ID: 15315478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.